Recombinant group B Streptococcus alpha-like protein 3 is an effective immunogen and carrier protein

Clinical and Vaccine Immunology

Volumn 15, Issue 7, 2008, Pages 1035-1041

  Yang, Hsiao Hui ^a   Mascuch, Samantha J ^a   Madoff, Lawrence C ^a   Paoletti, Lawrence C ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b CHANNING LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA LIKE PROTEIN 3; ANTIGEN; BACTERIAL POLYSACCHARIDE; BACTERIAL PROTEIN; CARRIER PROTEIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PROTEIN RIB; RECOMBINANT ALPHA LIKE PROTEIN 3; RECOMBINANT BETA C PROTEIN; RECOMBINANT PROTEIN; STREPTOCOCCUS VACCINE;

ADOLESCENT; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BINDING SITE; CONTROLLED STUDY; CROSS REACTION; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOGENICITY; LEUKOCYTE; MOUSE; NEWBORN; NONHUMAN; OPSONIZATION; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; SURVIVAL;

ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL CAPSULES; BACTERIAL PROTEINS; FEMALE; MICE; PHAGOCYTOSIS; RECOMBINANT PROTEINS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCAL VACCINES; STREPTOCOCCUS AGALACTIAE; VACCINES, CONJUGATE;

EID: 47649121199     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00030-08     Document Type: Article

References (47)

1. Baker, C. J., and M. S. Edwards. 2003. Group B streptococcal conjugate vaccines. Arch. Dis. Child. 88:375-378.
2. Baker, C. J., and D. L. Kasper. 1985. Group B streptococcal vaccines. Rev. Infect. Dis. 7:458-467.
3. Baker, C. J., L. C. Paoletti, M. A. Rench, H.-K. Guttormsen, M. S. Edwards, and D. L. Kasper. 2004. Immune response of healthy women to 2 different group B streptococcal type V capsular polysaccharide-protein conjugate vaccines. J. Infect. Dis. 189:1103-1112.
4. Baker, C. J., M. A. Rench, M. S. Edwards, R. J. Carpenter, B. M. Hays, and D. L. Kasper. 1988. Immunization of pregnant women with a polysaccharide vaccine of group B Streptococcus. N. Engl. J. Med. 319:1180-1185.
5. Baltimore, R. S., D. L. Kasper, C. J. Baker, and D. K. Goroff. 1977. Antigenic specificity of opsonophagocytic antibodies in rabbit anti-sera to group B streptococci. J. Immunol. 118:673-678.
6. Barington, T., M. Skettrup, L. Juul, and C. Heilmann. 1993. Non-epitope-specific suppression of the antibody response to Haemophilus influenzae type b conjugate vaccines by preimmunization with vaccine components. Infect. Immun. 61:432-438.
7. Baron, M. J., G. R. Bolduc, M. B. Goldberg, T. C. Aupérin, and L. C. Madoff. 2004. Alpha C protein of group B Streptococcus binds host cell surface glycosaminoglycan and enters cells by an actin-dependent mechanism. J. Biol. Chem. 279:24714-24723.
8. Brimil, N., E. Barthell, U. Heindrichs, M. Kuhn, R. Lutticken, and B. Spellerberg. 2006. Epidemiology of Streptococcus agalactiae colonization in Germany. Int. J. Med. Microbiol. 296:39-44.
9. Brodeur, B. R., M. Boyer, I. Charlebois, J. Hamel, F. Couture, C. R. Rioux, and D. Martin. 2000. Identification of group B streptococcal Sip protein, which elicits cross-protective immunity. Infect. Immun. 68:5610-5618.
10. Burrage, M., A. Robinson, R. Borrow, N. Andrews, J. Southern, J. Findlow, S. Martin, C. Thornton, D. Goldblatt, M. Corbel, D. Sesardic, K. Cartwight, P. Richmond, and E. Miller. 2002. Effect of vaccination with carrier protein on response to meningococcal C conjugate vaccines and value of different immunoassays as predictors of protection. Infect. Immun. 70:4946-4954.
11. Cheng, Q., B. Carlson, S. Pillai, R. Eby, L. Edwards, S. B. Olmsted, and P. Cleary. 2001. Antibody against surface-bound C5a peptidase is opsonic and initiates macrophage killing of group B streptococci. Infect. Immun. 69:2302-2308.
12. Dagan, R., J. Eskola, C. Leclerc, and O. Leroy. 1998. Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants. Infect. Immun. 66:2093-2098.
13. Darkes, M. J., and G. L. Plosker. 2002. Pneumococcal conjugate vaccine (Prevnar; PNCRM7): a review of its use in the prevention of Streptococcus pneumoniae infection. Paediatr. Drugs 4:609-630.
14. Edwards, M. S., and C. J. Baker. 2005. Group B streptococcal infections in elderly adults. Clin. Infect. Dis. 41:839-847.
15. Finn, A. 2004. Bacterial polysaccharide-protin conjugate vaccines. Br. Med. Bull. 70:1-14.
16. Fluegge, K., S. Supper, A. Siedler, and R. Berner. 2005. Serotype distribution of invasive group B streptococcal isolates in infants: results from a nationwide active laboratory surveillance study over 2 years in Germany. Clin. Infect. Dis. 40:760-763.
17. Gravekamp, C., D. L. Kasper, L. C. Paoletti, and L. C. Madoff. 1999. Alpha C protein as a carrier for type III capsular polysaccharide and as a protective protein in group B streptococcal vaccines. Infect. Immun. 67:2491-2496.
18. Gray, K. J., S. L. Bennett, N. French, A. J. Phiri, and S. M. Graham. 2007. Invasive group B streptococcal infection in infants, Malawi. Emerg. Infect. Dis. 13:223-229.
19. Harrison, L. H., J. A. Elliott, and D. M. Dwyer. 1998. Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation. J. Infect. Dis. 177:998-1002.
20. Johri, A. K., L. C. Paoletti, P. Glaser, M. Dua, P. K. Sharma, G. Grandi, and R. Rappuoli. 2006. Group B Streptococcus: global incidence and vaccine development. Nat. Rev. Microbiol. 4:932-942.
21. Kong, F., H. F. Gidding, R. Berner, and G. L. Gilbert. 2006. Streptococcus agalactiae Cβ protein gene (bac) sequence types, based on the repeated region of the cell-wall-spanning domain: relationship to virulence and a proposed standardized nomenclature. J. Med. Microbiol. 55:829-837.
22. Kong, F., S. Gowan, D. Martin, G. James, and G. L. Gilbert. 2002. Molecular profiles of group B streptococcal surface protein antigen genes: relationship to molecular serotypes. J. Clin. Microbiol. 40:620-626.
23. Lachenauer, C. S., C. J. Baker, M. J. Baron, D. L. Kasper, C. Gravekamp, and L. C. Madoff. 2002. Quantitative determination of immunoglobulin G specific for group B streptococcal β C protein in human maternal serum. J. Infect. Dis. 185:368-374.
24. Lachenauer, C. S., R. Creti, J. L. Michel, and L. C. Madoff. 2000. Mosaicism in the alpha-like protein genes of group B streptococci. Proc. Natl. Acad. Sci. USA 97:9630-9635.
25. Lachenauer, C. S., D. L. Kasper, J. Shimada, Y. Ichiman, H. Ohtsuka, M. Kaku, L. C. Paoletti, P. Ferrieri, and L. C. Madoff. 1999. Serotypes VI and VIII predominate among group B streptococci isolated from pregnant Japanese women. J. Infect. Dis. 179:1030-1033.
26. Lachenauer, C. S., and L. C. Madoff. 1996. A protective surface protein from type V group B streptococci shares N-terminal sequence homology with the alpha C protein. Infect. Immun. 64:4255-4260.
27. Lancefield, R., M. McCarty, and W. Everly. 1975. Multiple mouse-protective antibodies directed against group B streptococci. Special reference to antibodies effective against protein antigens. J. Exp. Med. 142:165-179.
28. Larsson, C., M. Lindroth, P. Nordin, M. Stalhammar-Carlemalm, G. Lindahl, and I. Krantz. 2006. Association between low concentrations of antibodies to protein a and Rib and invasive neonatal group B streptococcal infection. Arch. Dis. Child. Fetal Neonatal Ed. 91:F403-F408.
29. Larsson, C., M. Stalhammar-Carlemalm, and G. Lindahl. 1996. Experimental vaccination against group B Streptococcus, an encapsulated bacterium, with highly purified preparations of cell surface proteins Rib and alpha. Infect. Immun. 64:3518-3523.
30. Reference deleted.
31. Lindahl, G., M. Stalhammar-Carlemalm, and T. Areschoug. 2005. Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens. Clin. Microbiol. Rev. 18:102-127.
32. Madoff, L. C., J. L. Michel, E. W. Gong, A. K. Rodewald, and D. L. Kasper. 1992. Protection of neonatal mice from group B streptococcal infection by maternal immunization with beta C protein. Infect. Immun. 60:4989-4994.
33. Madoff, L. C., L. C. Paoletti, J. Y. Tai, and D. L. Kasper. 1994. Maternal immunization of mice with group B streptococcal type III polysaccharide-beta C protein conjugate elicits protective antibody to multiple serotypes. J. Clin. Investig. 94:286-292.
34. Maeland, J. A., L. Bevanger, and R. V. Lyng. 2004. Antigenic determinants of alpha-like proteins of Streptococcus agalactiae. Clin. Diagn. Lab. Immunol. 11:1035-1039.
35. Maeland, J. A., L. Bevanger, and R. V. Lyng. 2005. Immunological markers of the R4 protein of Streptococcus agalactiae. Clin. Diagn. Lab. Immunol. 12:1305-1310.
36. Maione, D., I. Margarit, C. D. Rinaudo, V. Masignani, M. Mora, M. Scarselli, H. Tettelin, C. Brettoni, E. T. Iacobini, R. Rosini, N. D'agostino, L. Miorin, S. Buccato, M. Mariani, G. Galli, and G. Grandi. 2005. Identification of a universal group B Streptococcus vaccine by multiple genome screen. Science 309:148-150.
37. Manning, S. D., S. Wood, K. Kasha, D. Martin, S. Rioux, B. R. Brodeur, and H. D. Davies. 2006. Naturally occurring antibodies for the group B streptococcal surface immunogenic protein (Sip) in pregnant women and newborn babies. Vaccine 24:6905-6912.
38. Martin, D., S. Rioux, E. Gagnon, M. Boyer, J. Hamel, N. Charland, and B. R. Brodeur. 2002. Protection from group B streptococcal infection in neonatal mice by maternal immunization with recombinant Sip protein. Infect. Immun. 70:4897-4901.
39. National Institutes of Health. 2007. The Jordan report: accelerated development of vaccines. NIH publication no. 06-6057. National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.
40. Paoletti, L. C., and D. L. Kasper. 2003. Glycoconjugate vaccines to prevent group B streptococcal infections. Expert Opin. Biol. Ther. 3:975-984.
41. Puopolo, K. M., and L. C. Madoff. 2007. Type IV neonatal early-onset group B streptococcal disease in a United States hospital. J. Clin. Microbiol. 45:1360-1362.
42. Ramaswamy, S. V., P. Ferrieri, A. E. Flores, and L. C. Paoletti. 2006. Molecular characterization of nontypeable group B Streptococcus. J. Clin. Microbiol. 44:2398-2403.
43. Stålhammar-Carlemalm, M., T. Areschoug, C. Larsson, and G. Lindahl. 2000. Cross-protection between group A and group B streptococci due to cross-reacting surface proteins. J. Infect. Dis. 182:142-149.
44. Stålhammar-Carlemalm, M., T. Areschoug, C. Larsson, and G. Lindahl. 1999. The R28 protein of Streptococcus pyogenes is related to several group B streptococcal surface proteins, confers protective immunity and promotes binding to human epithelial cells. Mol. Microbiol. 33:208-219.
45. Stalhammar-Carlemalm, M., L. Stenberg, and G. Lindahl. 1993. Protein Rib: a novel group B streptococcal cell surface protein that confers protective immunity and is expressed by most strains causing invasive infections. J. Exp. Med. 177:1593-1603.
46. Wessels, M., L. Paoletti, D. Kasper, J. DiFabio, F. Michon, K. Holme, and H. Jennings. 1990. Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B streptococcus. J. Clin. Investig. 86:1428-1433.
47. Yang, H.-H., L. C. Madoff, H.-K. Guttormsen, Y.-D. Liu, and L. C. Paoletti. 2007. Recombinant group B Streptococcus beta C protein and a variant with the deletion of its immunoglobulin A-binding site are protective mouse maternal vaccines and effective carriers in conjugate vaccines. Infect. Immun. 75:3455-3461.